Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITDAEPS (Basic)EPS (Weighted Average and Diluted)Income towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Summit Therapeutics (SMMT) Tax Rate (2016 - 2020)

Summit Therapeutics filings provide 7 years of Tax Rate readings, the most recent being 0.15% for Q4 2020.

  • Quarterly Tax Rate changed N/A to 0.15% in Q4 2020 from the year-ago period, while the trailing twelve-month figure was 0.03% through Sep 2021, up 143.0% year-over-year, with the annual reading at 0.4% for FY2020, 51.0% up from the prior year.
  • Tax Rate hit 0.15% in Q4 2020 for Summit Therapeutics, down from 0.31% in the prior quarter.
  • Across five years, Tax Rate topped out at 13.31% in Q3 2017 and bottomed at 45.42% in Q4 2017.
  • Average Tax Rate over 5 years is 10.01%, with a median of 13.2% recorded in 2019.
  • The largest annual shift saw Tax Rate crashed -2882bps in 2017 before it surged 3186bps in 2018.
  • Summit Therapeutics' Tax Rate stood at 16.6% in 2016, then soared by 100bps to 0.01% in 2017, then tumbled by -114433bps to 13.56% in 2018, then soared by 31bps to 9.37% in 2019, then skyrocketed by 102bps to 0.15% in 2020.
  • Per Business Quant, the three most recent readings for SMMT's Tax Rate are 0.15% (Q4 2020), 0.31% (Q3 2020), and 1.23% (Q2 2020).